BURN RELIEF

BURN RELIEF was reported 0 times

These side effects are most commonly reported by patients taking BURN RELIEF:

# Side effect Count
0 DRUG INEFFECTIVE 3671
1 PAIN 3213
2 FATIGUE 3108
3 NAUSEA 3093
4 HEADACHE 2856
5 OFF LABEL USE 2678
6 DYSPNOEA 2217
7 PNEUMONIA 2054
8 DIARRHOEA 2011
9 SINUSITIS 1951
10 VOMITING 1886
11 FALL 1739
12 PRODUCT DOSE OMISSION ISSUE 1738
13 DIZZINESS 1733
14 DEATH 1711
15 PYREXIA 1658
16 HYPOTENSION 1625
17 URINARY TRACT INFECTION 1509
18 ANXIETY 1464
19 COVID-19 1400
20 RASH 1391
21 MALAISE 1385
22 ARTHRALGIA 1383
23 BACK PAIN 1359
24 COUGH 1337
25 TOXICITY TO VARIOUS AGENTS 1260
26 ASTHENIA 1252
27 RENAL FAILURE 1185
28 PAIN IN EXTREMITY 1178
29 WEIGHT DECREASED 1151
30 PRODUCT USE IN UNAPPROVED INDICATION 1119
31 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1098
32 PRURITUS 1095
33 NASOPHARYNGITIS 1079
34 HYPERTENSION 1015
35 CARDIAC ARREST 985
36 CONSTIPATION 980
37 ACUTE KIDNEY INJURY 911
38 CONDITION AGGRAVATED 905
39 DECREASED APPETITE 860
40 BRONCHITIS 855
41 SOMNOLENCE 852
42 ABDOMINAL PAIN 833
43 ILLNESS 833
44 CHRONIC KIDNEY DISEASE 828
45 INFECTION 822
46 ANAPHYLACTIC REACTION 801
47 DEPRESSION 801
48 ANAEMIA 799
49 DRUG HYPERSENSITIVITY 798
50 CHEST PAIN 789
51 DRUG INTERACTION 784
52 INSOMNIA 777
53 UPPER RESPIRATORY TRACT INFECTION 769
54 SEPSIS 740
55 BLOOD PRESSURE INCREASED 737
56 ERYTHEMA 722
57 PRODUCT USE ISSUE 715
58 INFLUENZA 710
59 CONFUSIONAL STATE 695
60 MUSCLE SPASMS 682
61 WEIGHT INCREASED 681
62 TACHYCARDIA 679
63 FEELING ABNORMAL 673
64 PERIPHERAL SWELLING 670
65 LOSS OF CONSCIOUSNESS 663
66 SEIZURE 663
67 GAIT DISTURBANCE 658
68 HYPOAESTHESIA 656
69 INFUSION RELATED REACTION 655
70 CHILLS 653
71 TREMOR 651
72 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 628
73 OVERDOSE 625
74 URTICARIA 619
75 INJURY 618
76 HYPERSENSITIVITY 616
77 INJECTION SITE PAIN 610
78 STRESS 604
79 DEHYDRATION 602
80 MIGRAINE 602
81 BRADYCARDIA 597
82 CONTUSION 594
83 EMOTIONAL DISTRESS 590
84 PARAESTHESIA 586
85 PRODUCT ADHESION ISSUE 559
86 ABDOMINAL PAIN UPPER 549
87 INFUSION SITE PAIN 546
88 UNEVALUABLE EVENT 538
89 ATRIAL FIBRILLATION 525
90 EAR INFECTION 518
91 ANAPHYLACTIC SHOCK 517
92 SWELLING 515
93 INSURANCE ISSUE 508
94 RESPIRATORY TRACT INFECTION 504
95 OEDEMA PERIPHERAL 503
96 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 502
97 FEBRILE NEUTROPENIA 500
98 PRODUCT QUALITY ISSUE 498
99 MYALGIA 488
100 OROPHARYNGEAL PAIN 483
101 ASTHMA 478
102 MUSCULAR WEAKNESS 473
103 ALOPECIA 469
104 NEUROPATHY PERIPHERAL 463
105 ABDOMINAL DISTENSION 461
106 ABDOMINAL DISCOMFORT 459
107 RESPIRATORY FAILURE 453
108 HEART RATE INCREASED 440
109 CEREBROVASCULAR ACCIDENT 438
110 VISION BLURRED 438
111 INTENTIONAL PRODUCT USE ISSUE 435
112 CELLULITIS 433
113 CHEST DISCOMFORT 433
114 HYPERHIDROSIS 432
115 RENAL INJURY 427
116 HYPOXIA 423
117 GASTROOESOPHAGEAL REFLUX DISEASE 422
118 SEASONAL ALLERGY 419
119 SYNCOPE 410
120 BLOOD PRESSURE DECREASED 406
121 MEMORY IMPAIRMENT 406
122 OXYGEN SATURATION DECREASED 402
123 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 401
124 GASTROINTESTINAL DISORDER 396
125 PRODUCTIVE COUGH 394
126 ANHEDONIA 392
127 MATERNAL EXPOSURE DURING PREGNANCY 390
128 PULMONARY EMBOLISM 388
129 DYSPHAGIA 385
130 INCORRECT DOSE ADMINISTERED 382
131 RENAL IMPAIRMENT 382
132 NECK PAIN 381
133 PLEURAL EFFUSION 380
134 PALPITATIONS 376
135 DRUG INTOLERANCE 375
136 END STAGE RENAL DISEASE 375
137 INFUSION SITE SWELLING 374
138 NEUTROPENIA 368
139 HERPES ZOSTER 366
140 INFUSION SITE ERYTHEMA 364
141 VIRAL INFECTION 360
142 FEAR 355
143 THROMBOSIS 354
144 HOSPITALISATION 351
145 VENTRICULAR TACHYCARDIA 350
146 JOINT SWELLING 347
147 INFLUENZA LIKE ILLNESS 345
148 OEDEMA 343
149 GENERAL PHYSICAL HEALTH DETERIORATION 340
150 DRY MOUTH 338
151 HAEMOGLOBIN DECREASED 336
152 ARTHRITIS 331
153 THROMBOCYTOPENIA 330
154 STAPHYLOCOCCAL INFECTION 326
155 BALANCE DISORDER 325
156 MUSCULOSKELETAL STIFFNESS 325
157 VISUAL IMPAIRMENT 320
158 PLATELET COUNT DECREASED 319
159 EPISTAXIS 317
160 UNRESPONSIVE TO STIMULI 308
161 NO ADVERSE EVENT 307
162 CYSTITIS 304
163 STOMATITIS 304
164 HAEMORRHAGE 302
165 MYOCARDIAL INFARCTION 301
166 BURNING SENSATION 300
167 AGITATION 298
168 SLEEP DISORDER 296
169 CATARACT 295
170 MULTIPLE ALLERGIES 295
171 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 295
172 FLUSHING 292
173 LETHARGY 292
174 THERAPY NON-RESPONDER 292
175 WHITE BLOOD CELL COUNT DECREASED 291
176 MENTAL STATUS CHANGES 290
177 GENERALISED TONIC-CLONIC SEIZURE 289
178 PULMONARY OEDEMA 289
179 RHEUMATOID ARTHRITIS 289
180 DISCOMFORT 288
181 EXPOSURE DURING PREGNANCY 286
182 INTENTIONAL PRODUCT MISUSE 285
183 DYSPEPSIA 284
184 HYPONATRAEMIA 284
185 CARDIAC DISORDER 280
186 NASAL CONGESTION 279
187 DRUG ABUSE 278
188 VENTRICULAR FIBRILLATION 278
189 BLOOD GLUCOSE INCREASED 277
190 DISEASE PROGRESSION 273
191 WHEEZING 273
192 DERMATITIS CONTACT 272
193 NEPHROLITHIASIS 272
194 NEURALGIA 270
195 DIABETES MELLITUS 267
196 TREATMENT FAILURE 261
197 CARDIO-RESPIRATORY ARREST 260
198 DYSARTHRIA 256
199 RHINORRHOEA 256
200 INFUSION SITE PRURITUS 255
201 VERTIGO 253
202 CARDIAC FAILURE CONGESTIVE 252
203 GASTROENTERITIS VIRAL 249
204 INFUSION SITE EXTRAVASATION 248
205 METHAEMOGLOBINAEMIA 247
206 LOWER RESPIRATORY TRACT INFECTION 245
207 CARDIOGENIC SHOCK 244
208 OSTEOARTHRITIS 244
209 HYPOKALAEMIA 243
210 HALLUCINATION 242
211 SWELLING FACE 242
212 EYE PAIN 241
213 DRY SKIN 240
214 INFUSION SITE HAEMORRHAGE 240
215 INJECTION SITE ERYTHEMA 239
216 DEEP VEIN THROMBOSIS 238
217 MULTI-ORGAN FAILURE 236
218 OSTEOPOROSIS 233
219 DYSPHONIA 232
220 MALIGNANT NEOPLASM PROGRESSION 231
221 LOCALISED INFECTION 230
222 COMA 229
223 CARDIAC FAILURE 226
224 RENAL FAILURE ACUTE 226
225 BACTERIAL INFECTION 224
226 SUICIDAL IDEATION 224
227 ADVERSE DRUG REACTION 223
228 DEPRESSED LEVEL OF CONSCIOUSNESS 222
229 FUNGAL INFECTION 222
230 LIMB INJURY 222
231 FLUID RETENTION 221
232 INFUSION SITE DISCHARGE 220
233 KIDNEY INFECTION 218
234 SINUS DISORDER 218
235 TINNITUS 218
236 AMNESIA 217
237 BLISTER 217
238 MOBILITY DECREASED 217
239 MULTIPLE ORGAN DYSFUNCTION SYNDROME 217
240 DYSPNOEA EXERTIONAL 216
241 FOETAL EXPOSURE DURING PREGNANCY 216
242 DELIRIUM 215
243 SPEECH DISORDER 215
244 MUSCULOSKELETAL PAIN 212
245 ELECTROCARDIOGRAM QT PROLONGED 211
246 GASTROINTESTINAL HAEMORRHAGE 209
247 NEPHROGENIC ANAEMIA 209
248 SURGERY 207
249 BLOOD CREATININE INCREASED 206
250 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 206
251 POOR VENOUS ACCESS 204
252 SINUS TACHYCARDIA 204
253 BLOOD CHOLESTEROL INCREASED 200
254 BONE PAIN 199
255 ARTHROPATHY 198
256 LUNG DISORDER 198
257 FIBROMYALGIA 197
258 SEPTIC SHOCK 197
259 ARRHYTHMIA 196
260 HOT FLUSH 196
261 MEDICATION ERROR 196
262 RESPIRATORY DISTRESS 196
263 ROAD TRAFFIC ACCIDENT 196
264 SKIN DISCOLOURATION 196
265 STATUS EPILEPTICUS 196
266 ANGIOEDEMA 195
267 NEUROTOXICITY 195
268 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 193
269 POST PROCEDURAL COMPLICATION 193
270 PANCYTOPENIA 192
271 THERAPY INTERRUPTED 188
272 ASPARTATE AMINOTRANSFERASE INCREASED 187
273 METABOLIC ACIDOSIS 187
274 RIB FRACTURE 185
275 DIPLOPIA 184
276 HEART RATE DECREASED 183
277 ALANINE AMINOTRANSFERASE INCREASED 182
278 SKIN EXFOLIATION 181
279 CONVULSION 180
280 INFUSION SITE BRUISING 179
281 FEELING HOT 178
282 INCORRECT DRUG ADMINISTRATION RATE 178
283 RASH PRURITIC 178
284 ACCIDENTAL OVERDOSE 177
285 INJECTION SITE SWELLING 177
286 ASCITES 176
287 DIVERTICULITIS 175
288 DYSGEUSIA 175
289 LYMPHADENOPATHY 172
290 CANDIDA INFECTION 171
291 HEAD INJURY 171
292 MENTAL DISORDER 171
293 DRUG DEPENDENCE 170
294 PREMATURE BABY 170
295 TOXIC ANTERIOR SEGMENT SYNDROME 170
296 CIRCULATORY COLLAPSE 169
297 ACUTE RESPIRATORY FAILURE 168
298 ENCEPHALOPATHY 167
299 HYPERKALAEMIA 167
300 RESPIRATORY ARREST 167
301 RESTLESSNESS 166
302 SKIN INFECTION 165
303 HAEMORRHOIDS 164
304 INFLAMMATION 164
305 PROCEDURAL PAIN 163
306 COGNITIVE DISORDER 162
307 RESPIRATORY DISORDER 162
308 TOOTH INFECTION 162
309 DISTURBANCE IN ATTENTION 161
310 DYSURIA 161
311 URINARY RETENTION 161
312 WHITE BLOOD CELL COUNT INCREASED 161
313 PNEUMONIA ASPIRATION 160
314 ACCIDENTAL EXPOSURE TO PRODUCT 159
315 DYSKINESIA 159
316 PRODUCT DISTRIBUTION ISSUE 159
317 BLOOD POTASSIUM DECREASED 157
318 MATERNAL EXPOSURE DURING DELIVERY 157
319 PAIN IN JAW 157
320 BLINDNESS 154
321 COLITIS 154
322 DRUG DOSE OMISSION 154
323 DRY EYE 154
324 INTENTIONAL OVERDOSE 153
325 RESPIRATORY DEPRESSION 153
326 PSORIASIS 152
327 RENAL DISORDER 152
328 FLATULENCE 151
329 THROAT IRRITATION 151
330 DEVICE ISSUE 150
331 NERVOUSNESS 150
332 SKIN ULCER 150
333 INTERVERTEBRAL DISC PROTRUSION 149
334 LIMB DISCOMFORT 149
335 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 149
336 RECTAL HAEMORRHAGE 149
337 DISORIENTATION 147
338 FOOT FRACTURE 147
339 URINARY INCONTINENCE 147
340 HYPOAESTHESIA ORAL 146
341 ANAESTHETIC COMPLICATION 145
342 BRONCHOSPASM 145
343 PHARYNGITIS STREPTOCOCCAL 145
344 INJECTION SITE BRUISING 144
345 ADVERSE EVENT 143
346 BODY TEMPERATURE INCREASED 143
347 SLEEP APNOEA SYNDROME 143
348 SHOCK 142
349 VISUAL ACUITY REDUCED 142
350 HEPATIC ENZYME INCREASED 141
351 HYPOTHYROIDISM 141
352 TENDERNESS 141
353 CLOSTRIDIUM DIFFICILE INFECTION 139
354 OSTEOMYELITIS 139
355 BRAIN OEDEMA 138
356 ORAL PAIN 138
357 SCAR 138
358 NEOPLASM MALIGNANT 137
359 SKIN LACERATION 137
360 MYDRIASIS 136
361 HAEMOPTYSIS 135
362 IMPAIRED HEALING 135
363 INJECTION SITE PRURITUS 135
364 LIP SWELLING 135
365 POOR QUALITY SLEEP 135
366 CROHN^S DISEASE 134
367 ECONOMIC PROBLEM 134
368 HYPERLIPIDAEMIA 134
369 SCIATICA 134
370 JOINT INJURY 133
371 NERVOUS SYSTEM DISORDER 133
372 POLLAKIURIA 133
373 RASH ERYTHEMATOUS 133
374 DRUG LEVEL INCREASED 132
375 SKIN DISORDER 132
376 SWOLLEN TONGUE 132
377 VENTRICULAR EXTRASYSTOLES 132
378 APHASIA 131
379 COMPLETED SUICIDE 131
380 PALLOR 131
381 ATELECTASIS 130
382 C-REACTIVE PROTEIN INCREASED 130
383 MYASTHENIA GRAVIS 130
384 NIGHT SWEATS 130
385 HAEMATOMA 129
386 SEROTONIN SYNDROME 129
387 STRESS CARDIOMYOPATHY 129
388 THERAPEUTIC RESPONSE DECREASED 128
389 APPENDICITIS 126
390 BLOOD PRESSURE ABNORMAL 126
391 CHOLELITHIASIS 126
392 MUSCULOSKELETAL CHEST PAIN 126
393 RESPIRATORY TRACT CONGESTION 126
394 APNOEA 125
395 GOUT 125
396 HAEMATURIA 125
397 HYPOPHOSPHATAEMIA 125
398 PHARYNGITIS 125
399 EYE IRRITATION 124
400 RED BLOOD CELL COUNT DECREASED 124
401 WOUND 124
402 INTESTINAL OBSTRUCTION 123
403 NEEDLE ISSUE 123
404 CYTOKINE RELEASE SYNDROME 122
405 HAEMATOCRIT DECREASED 122
406 HAEMODYNAMIC INSTABILITY 122
407 MUCOSAL INFLAMMATION 122
408 THERAPY PARTIAL RESPONDER 122
409 ACUTE MYOCARDIAL INFARCTION 121
410 PULSELESS ELECTRICAL ACTIVITY 121
411 TRANSIENT ISCHAEMIC ATTACK 121
412 GAIT INABILITY 120
413 INJECTION SITE REACTION 120
414 PRODUCT DOSE OMISSION 120
415 EAR PAIN 119
416 EYE INFECTION 119
417 PULMONARY HYPERTENSION 119
418 TOOTH DISORDER 119
419 MUSCLE TWITCHING 118
420 OCULAR HYPERAEMIA 118
421 APPLICATION SITE PAIN 117
422 ILL-DEFINED DISORDER 117
423 MYOCLONUS 117
424 HAEMATOCHEZIA 116
425 NEUTROPHIL COUNT DECREASED 116
426 CYANOSIS 115
427 ULCER 115
428 INTERVERTEBRAL DISC DEGENERATION 114
429 IRRITABILITY 114
430 PNEUMOTHORAX 114
431 BONE DENSITY DECREASED 113
432 HIP FRACTURE 113
433 IMPAIRED GASTRIC EMPTYING 113
434 SPINAL FRACTURE 113
435 SPINAL OSTEOARTHRITIS 113
436 DRUG WITHDRAWAL SYNDROME 112
437 ECZEMA 112
438 LIVER DISORDER 112
439 OSTEOPENIA 112
440 PRESYNCOPE 112
441 SINUS BRADYCARDIA 112
442 DEPRESSED MOOD 111
443 HYPERPARATHYROIDISM SECONDARY 111
444 MUSCULOSKELETAL DISCOMFORT 111
445 BLOOD GLUCOSE DECREASED 110
446 DISABILITY 110
447 PLASMA CELL MYELOMA 110
448 TACHYPNOEA 110
449 THERAPEUTIC RESPONSE UNEXPECTED 110
450 IRRITABLE BOWEL SYNDROME 109
451 KOUNIS SYNDROME 109
452 TREATMENT NONCOMPLIANCE 109
453 DEVICE INFUSION ISSUE 108
454 DYSSTASIA 108
455 FEELING COLD 108
456 GASTROINTESTINAL INFECTION 108
457 PREMATURE DELIVERY 108
458 ROTATOR CUFF SYNDROME 108
459 WEIGHT FLUCTUATION 108
460 CONJUNCTIVITIS 107
461 ORAL HERPES 107
462 ORAL CANDIDIASIS 106
463 SKIN LESION 106
464 THERAPEUTIC PRODUCT EFFECT DECREASED 106
465 BRAIN FOG 105
466 CORONARY ARTERY DISEASE 105
467 HYPOGLYCAEMIA 105
468 LEUKOCYTOSIS 105
469 PANCREATITIS 104
470 HYPERSOMNIA 103
471 PARAESTHESIA ORAL 103
472 PRODUCT DOSE OMISSION IN ERROR 103
473 TOOTH ABSCESS 103
474 CARPAL TUNNEL SYNDROME 101
475 CHROMATURIA 101
476 HIATUS HERNIA 101
477 LIVE BIRTH 101
478 PANIC ATTACK 101
479 TUBULOINTERSTITIAL NEPHRITIS 101
480 UPPER LIMB FRACTURE 101
481 APPLICATION SITE ERYTHEMA 99
482 COVID-19 PNEUMONIA 99
483 HORNER^S SYNDROME 99
484 TOOTHACHE 99
485 GASTRITIS 98
486 LIVER FUNCTION TEST INCREASED 98
487 NERVE INJURY 98
488 PULMONARY MASS 98
489 SINUS CONGESTION 98
490 INFUSION SITE MASS 97
491 INTENTIONAL DOSE OMISSION 97
492 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 97
493 RASH MACULAR 97
494 SKIN IRRITATION 97
495 IMPAIRED QUALITY OF LIFE 96
496 INCORRECT ROUTE OF DRUG ADMINISTRATION 96
497 LACRIMATION INCREASED 96
498 MASS 96
499 PULSE ABSENT 96
500 RESPIRATORY SYNCYTIAL VIRUS INFECTION 96
501 AGGRESSION 95
502 BACK DISORDER 95
503 HEART RATE IRREGULAR 95
504 INJECTION SITE HAEMORRHAGE 95
505 LEUKOPENIA 95
506 THROAT TIGHTNESS 95
507 BLOOD PRESSURE FLUCTUATION 94
508 HALLUCINATION, VISUAL 94
509 HYPERPHOSPHATAEMIA 94
510 IRON DEFICIENCY 94
511 CEREBRAL HAEMORRHAGE 93
512 HYPOACUSIS 93
513 PRODUCT ADMINISTRATION INTERRUPTED 93
514 SEDATION 93
515 SYSTEMIC LUPUS ERYTHEMATOSUS 93
516 BLOOD PHOSPHORUS INCREASED 92
517 MULTIPLE SCLEROSIS RELAPSE 92
518 OSTEONECROSIS 92
519 PSEUDOMONAS INFECTION 92
520 SPINAL PAIN 92
521 WITHDRAWAL SYNDROME 92
522 DECUBITUS ULCER 91
523 DRUG EFFECT DECREASED 91
524 OBSTRUCTION 91
525 RHABDOMYOLYSIS 91
526 ANKLE FRACTURE 90
527 BLOOD BILIRUBIN INCREASED 90
528 BONE DISORDER 90
529 BRONCHIECTASIS 90
530 INFUSION SITE REACTION 90
531 MOUTH ULCERATION 90
532 APPENDICOLITH 89
533 BLOOD URIC ACID INCREASED 89
534 DRUG TOXICITY 89
535 HYPERGLYCAEMIA 89
536 PERICARDIAL EFFUSION 89
537 PHOTOPHOBIA 89
538 PNEUMONITIS 89
539 PSORIATIC ARTHROPATHY 89
540 CARDIOMEGALY 88
541 DEVICE DISLOCATION 88
542 EATING DISORDER 88
543 EYE DISORDER 88
544 HEMIPARESIS 88
545 INSPIRATORY CAPACITY DECREASED 88
546 JOINT STIFFNESS 88
547 SUICIDE ATTEMPT 88
548 BLOOD SODIUM DECREASED 87
549 BLOOD UREA INCREASED 87
550 EYE SWELLING 87
551 HERNIA 87
552 PARALYSIS 87
553 PRODUCT AVAILABILITY ISSUE 87
554 BLOOD URINE PRESENT 86
555 CRYING 86
556 DEVICE RELATED INFECTION 86
557 LOWER LIMB FRACTURE 86
558 PROCTALGIA 86
559 RENAL TUBULAR NECROSIS 86
560 RESTLESS LEGS SYNDROME 86
561 SENSORY LOSS 86
562 ABSCESS 85
563 POST PROCEDURAL INFECTION 85
564 STREPTOCOCCAL INFECTION 85
565 TASTE DISORDER 85
566 TROPONIN INCREASED 85
567 BREAST CANCER 84
568 CARDIOTOXICITY 84
569 LYMPHOCYTE COUNT DECREASED 84
570 PULMONARY CONGESTION 84
571 SMALL INTESTINAL OBSTRUCTION 84
572 TORSADE DE POINTES 84
573 BLOOD ALKALINE PHOSPHATASE INCREASED 83
574 BURSITIS 83
575 EJECTION FRACTION DECREASED 83
576 INFUSION SITE RASH 83
577 LIGAMENT SPRAIN 83
578 MUSCLE TIGHTNESS 83
579 NEOPLASM PROGRESSION 83
580 COLD SWEAT 82
581 HYPOPHAGIA 82
582 MOVEMENT DISORDER 82
583 MULTIPLE SCLEROSIS 82
584 RETCHING 82
585 SNEEZING 82
586 SUPRAVENTRICULAR TACHYCARDIA 82
587 ALTERED STATE OF CONSCIOUSNESS 81
588 ANGINA PECTORIS 81
589 CLOSTRIDIUM DIFFICILE COLITIS 81
590 DYSTONIA 81
591 GLAUCOMA 81
592 INJECTION SITE MASS 81
593 APHONIA 80
594 DEAFNESS 80
595 MENTAL IMPAIRMENT 80
596 OBSTRUCTIVE AIRWAYS DISORDER 80
597 PRODUCT SUBSTITUTION ISSUE 80
598 DEVICE MALFUNCTION 78
599 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 78
600 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 78
601 PRODUCT ADMINISTRATION ERROR 78
602 BACTERAEMIA 77
603 GASTRIC DISORDER 77
604 HEPATIC FAILURE 77
605 LARYNGITIS 77
606 NERVE COMPRESSION 77
607 RASH MACULO-PAPULAR 77
608 VITREOUS FLOATERS 77
609 COAGULOPATHY 76
610 JOINT RANGE OF MOTION DECREASED 76
611 OSTEONECROSIS OF JAW 76
612 PRODUCT PRESCRIBING ISSUE 76
613 ACUTE RESPIRATORY DISTRESS SYNDROME 75
614 ASPIRATION 75
615 ESCHERICHIA INFECTION 75
616 FACIAL PAIN 75
617 GRAND MAL CONVULSION 75
618 HEREDITARY ANGIOEDEMA 75
619 MALNUTRITION 75
620 NODULE 75
621 REBOUND ACID HYPERSECRETION 75
622 SKIN ABRASION 75
623 SPINAL OPERATION 75
624 TYPE 2 DIABETES MELLITUS 75
625 ACCIDENT 74
626 CARDIOMYOPATHY 74
627 CONCUSSION 74
628 DERMATITIS 74
629 FULL BLOOD COUNT DECREASED 74
630 INCONTINENCE 74
631 IRON DEFICIENCY ANAEMIA 74
632 BASAL CELL CARCINOMA 73
633 BLOOD PRESSURE SYSTOLIC INCREASED 73
634 ENDOPHTHALMITIS 73
635 INTERSTITIAL LUNG DISEASE 73
636 VASCULAR DEVICE INFECTION 73
637 WOUND INFECTION 73
638 ACNE 72
639 EYELID PTOSIS 72
640 INCORRECT PRODUCT ADMINISTRATION DURATION 72
641 PROCEDURAL COMPLICATION 72
642 PULMONARY FIBROSIS 72
643 SKIN CANCER 72
644 VAGINAL HAEMORRHAGE 72
645 AUTOIMMUNE DISORDER 71
646 CHRONIC SINUSITIS 71
647 EMOTIONAL DISORDER 71
648 EPILEPSY 71
649 FEEDING DISORDER 71
650 HYPERAESTHESIA 71
651 HYPOMAGNESAEMIA 71
652 ATAXIA 70
653 EXOSTOSIS 70
654 FOOD ALLERGY 70
655 GALLBLADDER DISORDER 70
656 JOINT DISLOCATION 70
657 LACTIC ACIDOSIS 70
658 MUSCLE STRAIN 70
659 SKIN BURNING SENSATION 70
660 VITAMIN D DEFICIENCY 70
661 BODY HEIGHT DECREASED 69
662 HEAD DISCOMFORT 69
663 PRODUCT PREPARATION ERROR 69
664 STEVENS-JOHNSON SYNDROME 69
665 ANAL INCONTINENCE 68
666 ARTHROPOD BITE 68
667 HEPATIC STEATOSIS 68
668 INTERNATIONAL NORMALISED RATIO INCREASED 68
669 NIGHTMARE 68
670 PREGNANCY 68
671 TOXIC EPIDERMAL NECROLYSIS 68
672 BLOOD TEST ABNORMAL 67
673 DEMENTIA 67
674 FACIAL PARALYSIS 67
675 MICTURITION URGENCY 67
676 MIOSIS 67
677 MITRAL VALVE INCOMPETENCE 67
678 THERAPEUTIC RESPONSE SHORTENED 67
679 HAEMATEMESIS 66
680 HEPATIC FUNCTION ABNORMAL 66
681 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 65
682 AGEUSIA 65
683 BACK INJURY 65
684 DISSEMINATED INTRAVASCULAR COAGULATION 65
685 FACE OEDEMA 65
686 FLANK PAIN 65
687 LEFT VENTRICULAR DYSFUNCTION 65
688 TENDONITIS 65
689 UPPER-AIRWAY COUGH SYNDROME 65
690 ACTIVITIES OF DAILY LIVING IMPAIRED 64
691 BUNDLE BRANCH BLOCK LEFT 64
692 COMPLICATION ASSOCIATED WITH DEVICE 64
693 DEVICE LEAKAGE 64
694 DRUG EFFECT INCOMPLETE 64
695 HYPERCHOLESTEROLAEMIA 64
696 MOTOR DYSFUNCTION 64
697 MUSCLE RIGIDITY 64
698 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 64
699 PSYCHOTIC DISORDER 64
700 TOOTH LOSS 64
701 WRONG TECHNIQUE IN DRUG USAGE PROCESS 64
702 BLOOD IRON DECREASED 63
703 BLOOD POTASSIUM INCREASED 63
704 ILEUS 63
705 MENINGITIS 63
706 NYSTAGMUS 63
707 PRE-EXISTING CONDITION IMPROVED 63
708 RASH PAPULAR 63
709 SPINAL DISORDER 63
710 THERAPY CESSATION 63
711 UNDERDOSE 63
712 WRIST FRACTURE 63
713 BLOOD CALCIUM INCREASED 62
714 BLOOD CREATINE PHOSPHOKINASE INCREASED 62
715 BRAIN INJURY 62
716 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 62
717 CORNEAL OEDEMA 62
718 EXPIRED PRODUCT ADMINISTERED 62
719 GASTRIC ULCER 62
720 PHARYNGEAL SWELLING 62
721 PNEUMONIA BACTERIAL 62
722 QUALITY OF LIFE DECREASED 62
723 RENAL CYST 62
724 RHINOVIRUS INFECTION 62
725 TYPE I HYPERSENSITIVITY 62
726 ANALGESIC THERAPY 61
727 AORTIC STENOSIS 61
728 DENTAL CARIES 61
729 DRUG THERAPY 61
730 GENERALISED OEDEMA 61
731 GLUCOSE TOLERANCE IMPAIRED 61
732 PRODUCT STORAGE ERROR 61
733 SLEEP DISORDER THERAPY 61
734 THYROID DISORDER 61
735 VASOPLEGIA SYNDROME 61
736 ABNORMAL BEHAVIOUR 60
737 CYST 60
738 ELECTROLYTE IMBALANCE 60
739 EMPHYSEMA 60
740 IMPAIRED WORK ABILITY 60
741 INADEQUATE ANALGESIA 60
742 LUNG INFECTION 60
743 MENINGITIS ASEPTIC 60
744 NEPHROPATHY 60
745 PARAPLEGIA 60
746 PHOTOSENSITIVITY REACTION 60
747 SPUTUM DISCOLOURED 60
748 INFUSION SITE URTICARIA 59
749 INFUSION SITE WARMTH 59
750 LABORATORY TEST ABNORMAL 59
751 MYOCARDIAL ISCHAEMIA 59
752 PERICARDITIS 59
753 POST PROCEDURAL HAEMORRHAGE 59
754 DEVICE OCCLUSION 58
755 DISEASE RECURRENCE 58
756 EYE PRURITUS 58
757 INABILITY TO AFFORD MEDICATION 58
758 INFUSION SITE DISCOMFORT 58
759 SPINAL COMPRESSION FRACTURE 58
760 TRANSAMINASES INCREASED 58
761 APPLICATION SITE RASH 57
762 ATRIOVENTRICULAR BLOCK COMPLETE 57
763 DERMATITIS ATOPIC 57
764 HOSPICE CARE 57
765 HYPERTENSIVE CRISIS 57
766 HYPERTHERMIA MALIGNANT 57
767 INFUSION SITE IRRITATION 57
768 LYMPHOEDEMA 57
769 RALES 57
770 UROSEPSIS 57
771 ABDOMINAL PAIN LOWER 56
772 ARTHRITIS BACTERIAL 56
773 BLADDER DISORDER 56
774 BLOOD CALCIUM DECREASED 56
775 DERMATITIS ALLERGIC 56
776 DEVICE DIFFICULT TO USE 56
777 NORMAL NEWBORN 56
778 OBESITY 56
779 PULMONARY THROMBOSIS 56
780 VENTRICULAR HYPOKINESIA 56
781 BLOOD TRIGLYCERIDES INCREASED 55
782 BREATH SOUNDS ABNORMAL 55
783 DRUG ADMINISTRATION ERROR 55
784 FOOT DEFORMITY 55
785 HYPOKINESIA 55
786 INTRAOCULAR PRESSURE INCREASED 55
787 LUNG INFILTRATION 55
788 LUNG OPACITY 55
789 METASTASES TO BONE 55
790 OTITIS MEDIA 55
791 SARS-COV-2 TEST POSITIVE 55
792 VENTRICULAR ARRHYTHMIA 55
793 ECCHYMOSIS 54
794 FOOD POISONING 54
795 GLOSSODYNIA 54
796 HEPATIC CIRRHOSIS 54
797 MOOD ALTERED 54
798 PERIPHERAL VASCULAR DISORDER 54
799 POSTOPERATIVE WOUND INFECTION 54
800 SENSITIVE SKIN 54
801 CONTRAINDICATED PRODUCT ADMINISTERED 53
802 DRUG EFFECT LESS THAN EXPECTED 53
803 HAND FRACTURE 53
804 PRODUCT PHYSICAL ISSUE 53
805 RESPIRATORY TRACT INFECTION VIRAL 53
806 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 52
807 APPLICATION SITE PRURITUS 52
808 ARTHRITIS INFECTIVE 52
809 FREQUENT BOWEL MOVEMENTS 52
810 HYPOCALCAEMIA 52
811 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 52
812 KNEE ARTHROPLASTY 52
813 NEUTROPHIL COUNT INCREASED 52
814 OCULAR DISCOMFORT 52
815 OESOPHAGITIS 52
816 PARANOIA 52
817 PROCEDURAL HYPOTENSION 52
818 PULMONARY ARTERIAL HYPERTENSION 52
819 TOOTH FRACTURE 52
820 ANAESTHETIC COMPLICATION NEUROLOGICAL 51
821 ARTERIOSCLEROSIS 51
822 DIZZINESS POSTURAL 51
823 FEMUR FRACTURE 51
824 HEPATOMEGALY 51
825 HYPERVOLAEMIA 51
826 JOINT EFFUSION 51
827 NEOPLASM 51
828 PARKINSON^S DISEASE 51
829 RETINAL HAEMORRHAGE 51
830 SKIN REACTION 51
831 SPINAL CORD COMPRESSION 51
832 TENDON RUPTURE 51
833 TRICUSPID VALVE INCOMPETENCE 51
834 CARDIOVASCULAR DISORDER 50
835 CAUDA EQUINA SYNDROME 50
836 COLITIS ULCERATIVE 50
837 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 50
838 FAECES DISCOLOURED 50
839 HAIR COLOUR CHANGES 50
840 HYPOALBUMINAEMIA 50
841 INFUSION SITE NODULE 50
842 ORTHOSTATIC HYPOTENSION 50
843 PELVIC PAIN 50
844 RHINITIS 50
845 DEAFNESS NEUROSENSORY 49
846 DEVICE BREAKAGE 49
847 EXTRAPYRAMIDAL DISORDER 49
848 GROIN PAIN 49
849 HEPARIN-INDUCED THROMBOCYTOPENIA 49
850 HORDEOLUM 49
851 ORAL DISORDER 49
852 RASH GENERALISED 49
853 RESPIRATORY ACIDOSIS 49
854 SCRATCH 49
855 SECRETION DISCHARGE 49
856 SKIN NECROSIS 49
857 SUBARACHNOID HAEMORRHAGE 49
858 VARICOSE VEIN 49
859 BEDRIDDEN 48
860 EXTRA DOSE ADMINISTERED 48
861 GINGIVAL BLEEDING 48
862 MACULAR DEGENERATION 48
863 MULTIPLE FRACTURES 48
864 PARADOXICAL DRUG REACTION 48
865 PERIPHERAL COLDNESS 48
866 PSYCHOMOTOR HYPERACTIVITY 48
867 RENAL PAIN 48
868 SENSORY DISTURBANCE 48
869 TOOTH EXTRACTION 48
870 ACUTE PULMONARY OEDEMA 47
871 BLOOD ALBUMIN DECREASED 47
872 CEREBRAL INFARCTION 47
873 EOSINOPHILIA 47
874 FLUID OVERLOAD 47
875 FULL BLOOD COUNT ABNORMAL 47
876 LUMBAR SPINAL STENOSIS 47
877 MELAENA 47
878 MUSCLE ATROPHY 47
879 POST-TRAUMATIC STRESS DISORDER 47
880 PRODUCT USE COMPLAINT 47
881 PURPURA 47
882 RETINAL DETACHMENT 47
883 APHTHOUS ULCER 46
884 BLOOD MAGNESIUM DECREASED 46
885 DIVERTICULUM 46
886 EYE INFLAMMATION 46
887 FEELING JITTERY 46
888 HAIR TEXTURE ABNORMAL 46
889 HYPOTONIA 46
890 IMMUNE SYSTEM DISORDER 46
891 IMMUNE THROMBOCYTOPENIA 46
892 LOW BIRTH WEIGHT BABY 46
893 PELVIC FRACTURE 46
894 SKIN FISSURES 46
895 ANIMAL BITE 45
896 CHOLECYSTITIS 45
897 DRUG EXPOSURE DURING PREGNANCY 45
898 DRUG-INDUCED LIVER INJURY 45
899 GINGIVITIS 45
900 HYPERCAPNIA 45
901 INJECTION SITE EXTRAVASATION 45
902 LUNG NEOPLASM MALIGNANT 45
903 MUSCLE SPASTICITY 45
904 MYOSITIS 45
905 OROPHARYNGEAL DISCOMFORT 45
906 POISONING 45
907 TRANSFUSION 45
908 WRONG PRODUCT ADMINISTERED 45
909 ACUTE CORONARY SYNDROME 44
910 ADRENAL INSUFFICIENCY 44
911 BEHAVIOUR DISORDER 44
912 CHOKING 44
913 IMMUNODEFICIENCY 44
914 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 44
915 MIDDLE INSOMNIA 44
916 PYELONEPHRITIS 44
917 RETINAL VASCULITIS 44
918 RHINITIS ALLERGIC 44
919 SKIN WARM 44
920 STAPHYLOCOCCAL SEPSIS 44
921 SYNOVITIS 44
922 ADMINISTRATION SITE PAIN 43
923 ATRIAL FLUTTER 43
924 CHOLECYSTECTOMY 43
925 DIALYSIS 43
926 DRUG ERUPTION 43
927 EYE DISCHARGE 43
928 FOURNIER^S GANGRENE 43
929 HIP ARTHROPLASTY 43
930 HYPERKERATOSIS 43
931 HYPERTHYROIDISM 43
932 INCREASED TENDENCY TO BRUISE 43
933 INGROWING NAIL 43
934 LAGOPHTHALMOS 43
935 LIVER INJURY 43
936 METASTASES TO CENTRAL NERVOUS SYSTEM 43
937 MUSCULOSKELETAL DISORDER 43
938 PAIN OF SKIN 43
939 PNEUMONIA FUNGAL 43
940 PRESCRIBED OVERDOSE 43
941 PROTEINURIA 43
942 RESPIRATION ABNORMAL 43
943 SCAB 43
944 SUBSTANCE ABUSE 43
945 THIRST 43
946 ATRIOVENTRICULAR BLOCK 42
947 BENIGN PROSTATIC HYPERPLASIA 42
948 CENTRAL NERVOUS SYSTEM LESION 42
949 DELUSION 42
950 EAR DISCOMFORT 42
951 HEPATITIS 42
952 HYPERTHERMIA 42
953 ISCHAEMIC STROKE 42
954 LIVER FUNCTION TEST ABNORMAL 42
955 PAPULE 42
956 PETECHIAE 42
957 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 42
958 RENAL FAILURE CHRONIC 42
959 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 42
960 SPINAL COLUMN STENOSIS 42
961 THINKING ABNORMAL 42
962 TOTAL LUNG CAPACITY DECREASED 42
963 BLINDNESS TRANSIENT 41
964 BLOOD PRESSURE DIASTOLIC DECREASED 41
965 CATHETER SITE PAIN 41
966 COMPLICATION OF DEVICE INSERTION 41
967 DEFORMITY 41
968 DIVERTICULUM INTESTINAL 41
969 ERYTHEMA MULTIFORME 41
970 EXTRASYSTOLES 41
971 EYE MOVEMENT DISORDER 41
972 HYDRONEPHROSIS 41
973 MAJOR DEPRESSION 41
974 METASTASES TO LUNG 41
975 PSYCHOLOGICAL TRAUMA 41
976 RED BLOOD CELL SEDIMENTATION RATE INCREASED 41
977 RIGHT VENTRICULAR FAILURE 41
978 STRIDOR 41
979 SUBDURAL HAEMATOMA 41
980 TRIGEMINAL NEURALGIA 41
981 ABNORMAL DREAMS 40
982 ANGER 40
983 BREAST CANCER METASTATIC 40
984 CARDIAC MURMUR 40
985 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 40
986 COMPRESSION FRACTURE 40
987 FAILURE TO THRIVE 40
988 INFUSION SITE INDURATION 40
989 INJECTION SITE DISCHARGE 40
990 LARYNGEAL OEDEMA 40
991 LARYNGOSPASM 40
992 MADAROSIS 40
993 RETINAL ARTERY OCCLUSION 40
994 SQUAMOUS CELL CARCINOMA 40
995 TEMPERATURE INTOLERANCE 40
996 WALKING AID USER 40
997 BLOOD GLUCOSE ABNORMAL 39
998 BRAIN HERNIATION 39
999 COORDINATION ABNORMAL 39